Category:

16 April 2025

ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING OF 16 APRIL 2025

09 April 2025

THE INTERNATIONALISATION PROCESS CONTINUES

08 April 2025

Allegato 3F – Marzo 2025

02 April 2025

NEWS AND UPDATES ON FOREIGN MARKETS

26 March 2025

ANOTHER YEAR WITH FERNANDO ALONSO

26 March 2025

FILING OF DOCUMENTS FOR THE SHAREHOLDERS’ MEETING

24 March 2025

SUCROSOMIAL IRON® MENTIONED IN THE GUIDELINES OF THE WORLD HEALTH ORGANISATION

21 March 2025

RENEWED THE PARTNERSHIP WITH AF CORSE

19 March 2025

PHARMANUTRA S.P.A. TO ATTEND THE EURONEXT STAR CONFERENCE 2025

17 March 2025

CLARIFICATION NOTE ON THE PRESS RELEASE OF 14.03.2025

14 March 2025

THE BOARD OF DIRECTORS APPROVES THE DRAFT FINANCIAL STATEMENTS AND THE CONSOLIDATED FINANCIAL STATEMENTS AS AT 31 DECEMBER 2024

04 March 2025

PHARMANUTRA SPA: BOARD OF DIRECTORS RESOLVES TO CONVENE THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS’ MEETING ON APRIL 16, 2025

13 January 2025

2024 PRELIMINARY SALES FIGURES

18 December 2024

2025 CORPORATE EVENTS CALENDAR PUBLICATION

25 November 2024

DISTRIBUTION AGREEMENT FOR SIDERAL® PRODUCTS SIGNED IN CANADA

18 November 2024

FIRST SIGNIFICANT SALES RESULTS IN CHINA

11 November 2024

PHARMANUTRA S.P.A.: THE BOD APPROVES THE INTERIM MANAGEMENT REPORT AS AT SEPTEMBER 30, 2024

04 November 2024

PHARMANUTRA S.P.A. APPLIES ITS PROPRIETARY SUCROSOMIAL® TECHNOLOGY TO VITAMINS AND LAUNCHES NEW SIDEVIT® LINE

29 October 2024

AGREEMENT WITH AN INTERNATIONAL ADVISOR IN ORDER TO DEFINE A DEVELOPMENT PLAN FOR PHARMANUTRA USA

02 October 2024

ALLEGATO 3F – SETTEMBRE 2024

09 September 2024

BOD APPROVED THE FIRST HALF FINANCIAL REPORT AS AT 30 JUNE 2024

1 2 … 12 >